Boehringer Ingelheim
Ivana Hezoucky

Regional Patient Safety Manager at Boehringer Ingelheim

  Austria

About me

I am a regional Patient Safety Manager with a decade of pharmacovigilance experience. I finished my MSc. degree in Animal Physiology and Ethology in Bratislava and started my professional carrer as the Multilingual Medical Information Officer in the United Kingdom. Since 2014 I have worked for Boehringer Ingelheim Regional Center Vienna in Austria, at first as a part of the Clinical Development Operations department. In 2017, I joined Regional Patient Safety and Pharmacovigilance team. In my current role, I have been responsible for various tasks including PV agreements, support of local Patient Safety Leads in the region, acting as PV business partner to Clinical Development Operations, working with external License Partner for establishing PV systems in countries without Boehringer Ingelheim office representation and ensuring local PV compliance in these countries. Recently I have supported several local PV inspections and audits as the CAPA Lead for PV and Med Info. I am passionate about the understanding of the whole medicine's lifecycle and dedicated to keep the compliance in patient safety high priority during times of global harmonization and digitalization. I take every opportunity to participate on various PV Awarness activities and enjoy speaking about patient safety internally and to external stakeholders, e.g taking a part on RCV Clinical Trials Ambassador Meetings and global pharmacovigilance conferences.

Schedule

My Session

Challenges and solutions regarding new PV legislation in non-EU countries, with a focus on clinical trial regulations
  • The value of a regional setup.
  • A summary of the differences between EU and non-EU PV regulations.
  • Our agility in implementing new PV legislation and guidelines.
  • Regulatory shifts in expanding clinical trial markets in Eastern Europe and CIS countries.

Ivana Hezoucky

Regional Patient Safety Manager at Boehringer Ingelheim


Regulatory Compliance
Global Pharmacovigilance
Panel Discussion: Beyond Compliance: Building a Proactive Drug Safety Culture

How leading organisations are embedding pharmacovigilance into decision-making, culture, and strategy - moving from reactive compliance to proactive patient safety.

  • How can pharmacovigilance move from a compliance function to a strategic driver of patient safety?
  • What does true cross-functional ownership of drug safety look like in practice?
  • Are current KPIs driving the right behaviours or just ticking boxes?
  • How can leadership create accountability for proactive safety decisions?

Quality Assurance
Patient Safety
Global Pharmacovigilance

Michael Ramcharan

Managing Director at Reumat Consulting

Ivana Hezoucky

Regional Patient Safety Manager at Boehringer Ingelheim

Judy Barretto

Senior Director at Gilead Sciences

Sandra Reda

Senior Pharmacovigilance Specialist at Newbridge Pharmaceuticals

Brian Edwards

Managing Director at Husoteria Ltd